Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FT1U0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,165.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,165.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award, issued on October 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 14, 2025. No set-aside designation was applied to this procurement, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal contracting. Performance will occur at the company's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply diverse pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods, positioning the company as a critical pharmaceutical supplier for global military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FT1U0?
SPE2DB26FT1U0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FT1U0 worth?
The government has obligated $4,166 on SPE2DB26FT1U0.
Is contract SPE2DB26FT1U0 an order under another contract?
Yes. SPE2DB26FT1U0 is a delivery order under SPE2DB20D9371, an indefinite delivery contract.
Was contract SPE2DB26FT1U0 competed?
The extent of competition for SPE2DB26FT1U0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award